These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 28209988

  • 1. Biopharma deal-making in 2016.
    Micklus A, Muntner S.
    Nat Rev Drug Discov; 2017 Mar; 16(3):161-162. PubMed ID: 28209988
    [No Abstract] [Full Text] [Related]

  • 2. Deal watch: Biopharma deal-making in 2015: changing the pharma landscape.
    Micklus A, Muntner S.
    Nat Rev Drug Discov; 2016 Feb; 15(2):78-9. PubMed ID: 26837586
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Deal watch: Trends in discovery externalization.
    Mayhew S.
    Nat Rev Drug Discov; 2010 Mar; 9(3):183. PubMed ID: 20190781
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI, Revel L, Rosa E, Cruces E.
    Drug News Perspect; 2009 Mar; 22(1):39-51. PubMed ID: 19209298
    [Abstract] [Full Text] [Related]

  • 9. Biotech acquisitions by big pharma: why and what is next.
    Malik NN.
    Drug Discov Today; 2009 Sep; 14(17-18):818-21. PubMed ID: 19584004
    [Abstract] [Full Text] [Related]

  • 10. China spurs pharma innovation.
    Hughes B.
    Nat Rev Drug Discov; 2010 Aug; 9(8):581-2. PubMed ID: 20671751
    [No Abstract] [Full Text] [Related]

  • 11. The challenges of product- and process-related impurities to an evolving biopharmaceutical industry.
    Bracewell DG, Smales CM.
    Bioanalysis; 2013 Jan; 5(2):123-6. PubMed ID: 23330553
    [No Abstract] [Full Text] [Related]

  • 12. Manufacturing, regulatory and commercial challenges of biopharmaceuticals production: a Finnish perspective.
    Närhi M, Nordström K.
    Eur J Pharm Biopharm; 2005 Apr; 59(3):397-405. PubMed ID: 15760720
    [Abstract] [Full Text] [Related]

  • 13. Biotech booms in China.
    Ellis S.
    Nature; 2018 Jan 18; 553(7688):S19-S22. PubMed ID: 29345681
    [No Abstract] [Full Text] [Related]

  • 14. Drug development: Sprint finish.
    Drew L.
    Nature; 2017 Nov 23; 551(7681):. PubMed ID: 29168826
    [No Abstract] [Full Text] [Related]

  • 15. A perfect storm for innovation.
    Williams RN.
    Clin Pharmacol Ther; 2010 Jul 23; 88(1):23; author reply 23-4. PubMed ID: 20445532
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biopharmaceutical process development - shortcut to market: an interview with Rolf Werner from Boehringer Ingelheim.
    Jungbauer A, Göbel U.
    Biotechnol J; 2012 Jan 23; 7(1):14-6. PubMed ID: 22228694
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deal watch: recent trends in deal-making.
    Dawkes A, Papp T.
    Nat Rev Drug Discov; 2010 Dec 23; 9(12):909. PubMed ID: 21119724
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.